PD patients with GBA mutations required DBS earlier in their disease course, because they developed disabling motor symptoms at an earlier stage despite conventional oral treatment, consistent with other published studies suggesting that patients with PD who have GBA mutations also have higher rates of cognitive decline (irrespective of DBS).18 Here, GBA1 is linked to Parkinson disease.